#USA #New York #TransPerfect #Trial Interactive #LiveTMF

TransPerfect's Innovative Partnership with Virtual Data Corp

In a significant stride towards improving clinical trial processes, TransPerfect's Trial Interactive has announced a strategic partnership with Virtual Data Corp. This collaboration introduces LiveTMF, a state-of-the-art compliance intelligence engine that aims to revolutionize how clinical trial documents are managed.

Clinical trials often face challenges in maintaining accurate and up-to-date documentation, especially as study parameters evolve. Traditionally, expected document lists (EDLs) have been treated as static, one-time setups. However, as trials progress, various factors such as site activations and protocol amendments can lead to discrepancies, resulting in a cumbersome reconciliation process before inspections.

With LiveTMF's integration into the Trial Interactive platform, this problem may soon become a thing of the past. By utilizing a cutting-edge compliance model developed by Virtual Data Corp, LiveTMF continuously updates the EDLs, ensuring they reflect the current state of the study. This real-time intelligence helps clinical teams minimize manual effort and reduce the risk of inspection failures through accurate, up-to-date documentation.

Michael Smyth, Division President at TransPerfect Life Sciences Solutions, emphasized the direction Trial Interactive has been heading towards for quite a while: "less configuration, more intelligence." He noted that LiveTMF’s dynamic nature allows clients to access a document list that aligns with the actual conduct of the study in real-time. This ability is especially crucial for maintaining compliance and operational efficiency in clinical trials.

Jordan Ellington, the Founder and CEO of Virtual Data Corp, echoed these sentiments by pointing out the fundamental issue with traditional EDLs: "Almost nobody trusts it. That is not a configuration problem, it is a modeling problem." He asserts that LiveTMF effectively builds the document list based on actual events, turning it into a functional work tool rather than a mere compliance checklist.

Importantly, LiveTMF is designed to function as a system-agnostic application, meaning it can operate alongside any leading eTMF providers without the need for system migration or revalidation. This flexibility opens new opportunities for institutions that want to enhance their compliance capabilities without overhauling their existing systems.

TransPerfect is set to make LiveTMF generally available in the fourth quarter of 2026. As clinical trials continue to evolve and adapt to new technologies, partnerships like that of TransPerfect and Virtual Data Corp could pave the way for more efficient and compliant study management. By integrating innovative solutions into clinical processes, the aim remains clear: reduce costs, improve operational excellence, and ensure the integrity of clinical trial data.

As the industry moves forward, both organizations appear committed to reshaping the landscape of clinical trials. Their collaborative efforts highlight a greater need for intelligent solutions that not only meet but exceed compliance expectations, safeguarding the interests of sponsors, CROs, and study sites worldwide.

For additional information on this collaboration and its implications for the clinical trial industry, be sure to check out TransPerfect's official channels. They not only provide insights into this partnership but also broader developments in clinical innovation and compliance.